Type 2 Antineuronal Nuclear Antibody in Nontumor Lambert-Eaton Myasthenic Syndrome: A Rare Association With Clinical Implications

J Clin Neuromuscul Dis. 2021 Jun 1;22(4):232-233. doi: 10.1097/CND.0000000000000314.

Authors

Vasiliki Zouvelou¹, Ariadne Daponte¹, Efstratios-Stylianos Pyrgelis¹, Fotini Boufidou²

Affiliations

¹ First Neurology Department, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Medical Biopathology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 34019010
DOI: 10.1097/CND.0000000000000314

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Antinuclear / immunology*
Antibodies, Neoplasm / immunology*
Female
Humans
Lambert-Eaton Myasthenic Syndrome / diagnosis
Lambert-Eaton Myasthenic Syndrome / immunology*

Substances

ANNA-2 antibody, human
Antibodies, Antinuclear
Antibodies, Neoplasm